blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1147771

EP1147771 - Pharmaceutical formulation containing amoxycillin and clavulanate [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  13.07.2012
Database last updated on 21.03.2026
Most recent event   Tooltip13.07.2012Refusal of applicationpublished on 15.08.2012  [2012/33]
Applicant(s)For all designated states
SMITHKLINE BEECHAM PLC
New Horizons Court Brentford
Middlesex TW8 9EP / GB
[N/P]
Former [2002/02]For all designated states
SMITHKLINE BEECHAM PLC
New Horizons Court
Brentford, Middlesex TW8 9EP / GB
Former [2001/43]For all designated states
SMITHKLINE BEECHAM CORPORATION
One Franklin Plaza P.O. Box 7929
Philadelphia Pennsylvania 19103 / US
Inventor(s)01 / Burch, Daniel Joseph, GlaxoSmithKline
1250 South Collegeville Road, PO Box 5089
Collegeville, PA 19426-0989 / US
 [2001/43]
Representative(s)Connell, Anthony Christopher, et al
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[N/P]
Former [2001/43]Connell, Anthony Christopher, et al
GlaxoSmithKline, Two New Horizons Court
Brentford, Middlesex TW8 9EP / GB
Application number, filing date01201824.805.09.1996
[2001/43]
Priority number, dateUS19950003353P07.09.1995         Original published format: US 3353 P
[2001/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1147771
Date:24.10.2001
Language:EN
[2001/43]
Search report(s)(Supplementary) European search report - dispatched on:EP04.09.2001
ClassificationIPC:A61K31/42
[2001/43]
CPC:
A61K45/06 (EP,KR,US); A61K31/43 (EP,KR,US); A61K31/397 (EP,US);
A61K31/424 (EP,KR,US); A61K9/0095 (EP,KR,US); A61K9/2054 (EP,KR,US);
A61K9/2059 (EP,KR,US); A61P11/00 (EP,KR); A61P27/16 (EP);
A61P31/00 (EP); A61P31/04 (EP) (-)
C-Set:
A61K31/397, A61K2300/00 (US,EP);
A61K31/424, A61K2300/00 (US,EP);
A61K31/43, A61K2300/00 (US,EP);
A61K31/43, A61K31/42 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/43]
Extension statesSI15.05.2001
TitleGerman:Pharmazeutische Zusammensetzung enhaltend Amoxycillin und Clavulanat[2001/43]
English:Pharmaceutical formulation containing amoxycillin and clavulanate[2001/43]
French:Composition pharmaceutique contenant de l'amoxicilline et du clavulanate[2001/43]
Examination procedure15.05.2001Examination requested  [2001/43]
22.10.2001Request for accelerated examination filed
11.02.2002Despatch of a communication from the examining division (Time limit: M04)
11.02.2002Decision about request for accelerated examination - accepted: Yes
26.04.2002Reply to a communication from the examining division
12.02.2003Date of oral proceedings
18.06.2003Despatch of communication that the application is refused, reason: substantive examination [2012/33]
18.06.2003Minutes of oral proceedings despatched
31.07.2007Application refused, date of legal effect [2012/33]
Appeal following examination12.08.2003Appeal received No.  T0214/04
24.10.2003Statement of grounds filed
31.07.2007Result of appeal procedure: appeal of the applicant was rejected
31.07.2007Date of oral proceedings
Parent application(s)   TooltipEP96930817.0  / EP0862431
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP19960930817) is  29.10.1999
Fees paidRenewal fee
15.05.2001Renewal fee patent year 03
15.05.2001Renewal fee patent year 04
15.05.2001Renewal fee patent year 05
15.05.2001Renewal fee patent year 06
05.09.2002Renewal fee patent year 07
04.09.2003Renewal fee patent year 08
06.09.2004Renewal fee patent year 09
05.09.2005Renewal fee patent year 10
08.09.2006Renewal fee patent year 11
05.09.2007Renewal fee patent year 12
05.09.2008Renewal fee patent year 13
Penalty fee
Additional fee for renewal fee
30.09.200914   M06   Not yet paid
30.09.201015   M06   Not yet paid
30.09.201116   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[E] WO9709042  (SMITHKLINE BEECHAM CORP et al.) [E] 1-11 * examples 1-3; claims 3-7,12,13 *
 [E] EP1044680  (BEECHAM PHARMACEUTICALS PTE LI et al.) [E] 1-11 * claims 10,19 *
 [A]   ROBINSON, C. P.: "Amoxicillin trihydrate / clavulanic acid potassium salt", MED. ACTUAL. (1982), 18(5), 213-19, XP000998104 [A] 1-11 * page 214 - page 215 *
 [A]   CHAN K H ET AL: "A comparative study of amoxicillin- clavulanate and amoxicillin. Treatment of otitis media with effusion.", ARCHIVES OF OTOLARYNGOLOGY -- HEAD AND NECK SURGERY, (1988 FEB) 114 (2) 142-6., XP000998115 [A] 1-11 * abstract *
 [A]   PICHICHERO M.E.: "Resistant respiratory pathogens and extended-spectrum antibiotics.", AMERICAN FAMILY PHYSICIAN, (1995) 52/6 (1739-1746)., XP000998283 [A] 1-11 * abstract *
 [A]   HOL C. ET AL: "Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia.", JOURNAL OF INFECTIOUS DISEASES, (1994) 170/6 (1613-1616)., XP000998294 [A] 1-11 * abstract *
 [X]   BARON S. ET AL: "[Antimicrobial therapy in acute otitis media]. TRAITEMENT ANTIBIOTIQUE DE L'OTITE MOYENNE AIGUE.", ANNALES DE PEDIATRIE, (1991) 38/8 (549-555)., XP000998113 [X] 1-11 * abstract *
 [A]   NEVILLE M.A.: "Augmentin: An in vitro study of bacterial sensitivities to a synergistic combination.", NEW ZEALAND MEDICAL JOURNAL, (1982) 95/714 (579-581). CODEN: NZMJAX, XP000998101 [A] 1-11 * abstract *
 [A]   ELLIS PEGLER R.B. ET AL: "Augmentin treatment of bacterial infections in hospitalised patients.", NEW ZEALAND MEDICAL JOURNAL, (1982) 95/713 (542-545). CODEN: NZMJAX, XP000998100 [A] 1-11 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.